As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

ROI is in the forecast – 49% say they expect to achieve ROI through better forecasting and decision-making, closely followed by a more cost effective and future proofed technology architecture and a ...

Biotech companies have brought many important treatments to market, from ones that address rare diseases to ones that handle ...

Vertex (VERX – Research Report), the Technology sector company, was revisited by a Wall Street analyst today. Analyst Chris Quintero from ...

These are the 300 companies whose success goes beyond profits to include employee and customer sentiment, cybersecurity, ...

Q3 2024 Earnings Call Transcript November 6, 2024 Operator: Good day, and welcome to the Vertex Inc. Third Quarter 2024 ...

Vertex's growth momentum remains strong, supported by ECC to S/4HANA migration and multi-year ERP upgrade cycle. Read my ...

Patients with rare diseases in India, like Saifullah Khalidi with spinal muscular atrophy (SMA), struggle to afford ...

From blue chip dividend stocks to industry-leading growth stocks, there are plenty of bargains in today's market if you know ...

John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Keith Speights has positions in Amazon and Vertex Pharmaceuticals. The Motley ...